| Rainbow BioSciences, LLC, the biotech subsidiary of Rainbow Coral Corp. (RBCC), today announced the collaboration of its latest target, Amarantus BioSciences, Inc. (OTCBB: AMBS), with Brewer Sports International (BSI) to increase awareness about new medical therapies in development to effectively treat traumatic brain injuries, commonly referred to as concussions, occurring primarily as a result of football and other contact sports. The Coalition for Concussion Treatment campaign, known under...continued RBCC |
Friday, May 4, 2012
RBCC Target's Brain Injury Treatment Awareness Campaign Reaches Milestone
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment